Explore the full directors' dealings record of AXIM BIOTECHNOLOGIES, INC., a listed issuer based in United States. Shares are listed on US US, under the authority of SEC (Form 4). Market capitalisation: €1.4m. The latest transaction was disclosed on 15 October 2024 (Acquisition). Among the most active insiders: Valencia Catalina. The full history is openly available.
5
Insider Decl.
0
Thresholds
€100,310
3 ops.
Buy Volume
·
0 ops.
Sell Volume
26Σ signal
Buys €100,310· Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.